Pfizer Inc. Logo

Pfizer Inc. (PFE)

NYSE

Currency in USD
27.97
-0.10 (-0.36%)

Closed

Aug 24, 2026

Day's Range

27.82
28.16

52 wk Range

23.58
28.75

Overview - PFE - Pfizer Inc.

Key Statistics

Valuation

Enterprise Value

212.06B

P/E (Trailing)

‪36.93‬

P/E (Forward)

‪9.69‬

PEG Ratio

‪-0.34‬

Price / Sales (TTM)

‪2.51‬

Price / Book

‪1.87‬

EV / EBITDA

‪8.35‬

Profitability

Gross Margin

‪72.78%‬

Profit Margin

‪6.80%‬

Operating Margin

‪27.87%‬

Return on Assets

‪5.78%‬

Return on Equity

‪5.01%‬

Ownership

Shares Outstanding

5.69B

Float

5.69B

Short % of Shares Outstanding

‪2.82%‬

Held by Insiders

‪0.10%‬

Held by Institutions

‪69.13%‬

Price stats

Beta

‪0.28‬

50-Day Avg

‪25.36‬

200-Day Avg

‪25.99‬

Dividends

Payout Ratio

‪226.32%‬

Frequency

Quarterly

Analyst Consensus

Hold

28 analysts

Average price target

‪$ 28.61‬

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 17, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - PFE - Pfizer Inc.

Peers - PFE - Pfizer Inc.

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on NYSE.

Profile Summary - PFE - Pfizer Inc.

About

Pfizer Inc. is a research-based global biopharmaceutical company founded in 1849 and headquartered in New York. It focuses on the discovery, development, manufacture, marketing, sales, and distribution of biopharmaceutical products worldwide, targeting developed and emerging markets to advance wellness, prevention,…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees75K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.